LINC00657 promotes the development of colon cancer by activating PI3K/AKT pathway.

Lei Y, Wang YH, Wang XF, Bai J

Open source

DOI
10.26355/eurrev_201810_16042
Published
2018 Oct
Container
European review for medical and pharmacological sciences
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.26355/eurrev_201810_16042,
  title = {LINC00657 promotes the development of colon cancer by activating PI3K/AKT pathway.},
  author = {Lei Y and Wang YH and Wang XF and Bai J},
  year = {2018},
  journal = {European review for medical and pharmacological sciences},
  doi = {10.26355/eurrev_201810_16042},
  url = {https://doi.org/10.26355/eurrev_201810_16042}
}

RIS

TY  - JOUR
TI  - LINC00657 promotes the development of colon cancer by activating PI3K/AKT pathway.
AU  - Lei Y
AU  - Wang YH
AU  - Wang XF
AU  - Bai J
PY  - 2018
JO  - European review for medical and pharmacological sciences
DO  - 10.26355/eurrev_201810_16042
UR  - https://doi.org/10.26355/eurrev_201810_16042
ER  - 

APA

Y, L., YH, W., XF, W., & J, B. (2018). LINC00657 promotes the development of colon cancer by activating PI3K/AKT pathway.. European review for medical and pharmacological sciences. https://doi.org/10.26355/eurrev_201810_16042

Source records